Obermatt

Journey Medical Corporation

NAQ:DERM · US48115J1097
PharmaceuticalsSmall

360

73
Profit price53
Cash yield1
Price/Sales77
EV / Gross Profit35
Price/Book30
Return on Capital33
Return on Equity34
EBIT Margin27
Gross Profitability91

Cash truth not applicable for financial companies.

Sales growth82
Profit growth27
Reinvestment1
Price momentum26
Debt load28
Debt serviceability76
Liquidity47
Analyst ratings100
Opinion Changes50
Price Target Upside66
Market mood19
Value Creation13/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Journey Medical Corporation clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Based on 3/5 components.

Profile

CountryUSA
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2014
Employees64
ISINUS48115J1097
Last UpdateApr 2, 2026
Index & Theme
DermatologyInflammationPharmaceutical

Description

Journey Medical Corporation operates as a commercial-stage pharmaceutical company. The company primarily focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment…

Analysis

Middle-of-the-road

Journey Medical Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is solid and the balance sheet is adequate. The company scores 13/20 on our value-creation score: creating some value. Analysts lean positive.

What to watch: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
21
2023202420252026

All-time high

54

Jan 2023

All-time low

9

Jan 2025

Average rank

22

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
77
76
69
92
Price/Earnings
18
80
80
80
Price/Book
30
13
5
94
Dividend Yield
1
1
1
1
Value (overall)
45
32
30
99

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Journey Medical Corporation with its peers
Grace Therapeutics
NAQ:GRCE
52
CountryUSA
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Turn Therapeutics
NMQ:TTRX
65
CountryUSA
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Vericel
NMQ:VCEL
82
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Structure Therapeutics
NMQ:GPCR
67
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Oramed Pharmaceuticals
NAQ:ORMP
47
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Insmed
NSQ:INSM
51
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →